19:15:17 EDT Mon 13 May 2024
Enter Symbol
or Name
USA
CA



Titan Medical Inc (2)
Symbol TMD
Shares Issued 112,842,297
Close 2023-08-11 C$ 0.205
Market Cap C$ 23,132,671
Recent Sedar Documents

Titan Medical appoints O'Brien as director

2023-08-14 13:58 ET - News Release

Mr. Paul Cataford reports

TITAN MEDICAL ANNOUNCES APPOINTMENT OF NEW INDEPENDENT MEMBER TO ITS BOARD OF DIRECTORS

Titan Medical Inc. has appointed Dr. Daniel O'Brien, MD, MBA, PhD, to its board of directors. Dr. O'Brien will also serve on the audit committee of the board.

"We are pleased to appoint Dr. O'Brien at the suggestion of a number of our shareholders," said Paul Cataford, interim chief executive officer and board chair. "We believe Dr. O'Brien will be a valuable resource as the company investigates various business combination alternatives."

About Dr. O'Brien

Dr. O'Brien is a physician and public health and business professional. Dr. O'Brien has a bachelor of arts from the University of Notre Dame, an MBA specializing in business administration in health care management from Donald E. Maine School of Business, an MD from WUSOM School of Medicine, and a PhD in public health epidemiology.

About Titan Medical Inc.

Titan Medical, a medical technology company headquartered in Toronto, Ont., has developed an expansive patent portfolio related to the enhancement of robotic-assisted surgery (RAS), including through a single access point, and is currently focused on evaluating new opportunities to further develop and license its intellectual property.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.